Source:http://linkedlifedata.com/resource/pubmed/id/11356827
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
2001-7-16
|
pubmed:abstractText |
Transforming growth factor-beta (TGF-beta) internalization was studied by monitoring the uptake of (125)I-TGF-beta1 in Mv1Lu cells, which endogenously express TGF-beta receptors types I (RI), II (RII), and III (RIII), and 293 cells transfected with RI and RII. At 37 degrees C internalization occurred rapidly, within 10 min of ligand addition. Internalization was optimal in 293 cells expressing both RI and RII. Internalization was prevented by phenylarsine oxide, a nonspecific inhibitor of receptor internalization, but was not affected by reagents that interfere with clathrin-mediated endocytosis such as monodansylcadaverine, K44A dynamin, and inhibitors of endosomal acidification. Electron microscopic examination of Mv1Lu cells treated with (125)I- TGF-beta1 at 37 degrees C indicated that internalization occurred via a noncoated vesicular mechanism. Internalization was prevented by prebinding cells with TGF-beta1 at 4 degrees C for 2 h prior to switching the cells to 37 degrees C. This was attributed to a loss of receptor binding, as indicated by a rapid decrease in the amount of TGF-beta1 bound to the cell surface at 37 degrees C and by a reduction in the labeling intensities of RI and RII in (125)I-TGF-beta1-cross-linking experiments. Mv1Lu or 293 (RI+RII) cells, prebound with TGF-beta1 at 4 degrees C and subsequently stripped of ligand by an acid wash, nevertheless initiated a signaling response upon transfer to 37 degrees C, suggesting that prebinding promotes formation of stable RI.RII complexes that can signal independently of ligand.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
27237-45
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11356827-Animals,
pubmed-meshheading:11356827-Cell Line,
pubmed-meshheading:11356827-Clathrin,
pubmed-meshheading:11356827-Endocytosis,
pubmed-meshheading:11356827-Humans,
pubmed-meshheading:11356827-Ligands,
pubmed-meshheading:11356827-Microscopy, Electron,
pubmed-meshheading:11356827-Mink,
pubmed-meshheading:11356827-Protein Binding,
pubmed-meshheading:11356827-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:11356827-Signal Transduction,
pubmed-meshheading:11356827-Transforming Growth Factor beta
|
pubmed:year |
2001
|
pubmed:articleTitle |
Transforming growth factor (TGF)-beta 1 internalization: modulation by ligand interaction with TGF-beta receptors types I and II and a mechanism that is distinct from clathrin-mediated endocytosis.
|
pubmed:affiliation |
Cell Surface Recognition Group, Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec H4P 2R2, Canada. john.zwaagstra@nrc.ca
|
pubmed:publicationType |
Journal Article
|